SlideShare a Scribd company logo
A methodological framework
for developing the structure
of Public Health economic
models
Dr Hazel Squires, ScHARR, University of Sheffield
Prof. Jim Chilcott, Prof. Ron Akehurst,
Dr. Jennifer Burr, Prof. Mike Kelly
Introduction
• Why we need a conceptual modelling framework
specific to Economic Modelling in Public Health
(PHE)
• Methods for developing the PHE conceptual
modelling framework
• An outline of the PHE conceptual modelling
framework
• Conclusions
Background
• Healthcare agencies such as the National
Institute for Health and Care Excellence (NICE)
need to decide how to spend their money.
• Mathematical models are used to provide a
rational, coherent & transparent framework of
the cost-effectiveness of healthcare
interventions.
• Inappropriately simple models and lack of
justification may lead to poor validity and
credibility, resulting in suboptimal allocation of
resources.
Current methods for dealing
with structural uncertainty
1) Retrospective: following model implementation
by expressing the impact of uncertainties upon
the model results.
• Scenario analysis
• Model averaging
2) Prospective: considering the process through
which decisions are made around the
conceptualisation, structuring and
implementation of the model.
• Model development practice in health economics is
extremely varied (Chilcott, 2010).
Chilcott J, Tappenden P, Rawdin A, Johnson M, Kaltenthaler E, Paisley S et al. Avoiding and identifying errors in health
technology assessment models: qualitative study and methodological review. Health Technol Assess 2010; 14(25).
What is a Conceptual
Modelling (CM) Framework?
• ‘A set of steps that help to guide modellers
through the development of a model structure,
from developing and describing an
understanding of the decision problem to the
abstraction and non-software specific
description of the quantitative model, using a
transparent approach which enables each stage
to be shared and questioned.’
Based upon Kaltenthaler E., Tappenden P., Paisley S. and Squires H. Identifying and reviewing evidence to inform the
conceptualisation and population of cost-effectiveness models, No. 14, 2011 and Robinson S. Conceptual
modelling for simulation Part I: definition and requirements. Journal of the Operational Research Society 2008;
59:278-290.
Key potential benefits of a
CM Framework
• Aids the development of modelling objectives;
• Provides tools for communication with stakeholders;
• Guides model development and experimentation;
• Improves model validation (developing the right model);
• Improves model verification (developing the model right);
• Allows model reuse;
• Helps to characterise structural uncertainties and identify
primary research needs.
Economic evaluation of Public
Health compared with clinical
interventions
• A key objective of Public Health is reduction of health
inequities;
• PH interventions tend to:
- Be multi-component with complex causal chains;
- Operate within dynamically complex systems;
- Be dependent upon human behaviour;
- Be dependent upon the social determinants of health,
requiring consideration of non-health costs & outcomes;
• It is much less clear what a ‘good’ outcome is;
• The culture & politics of the system is important in
choosing & assessing interventions
Methods for developing PHE
conceptual modelling framework
1) Literature review of key challenges in PHE modelling
(Squires et al., 2016)
2) Review of conceptual modelling frameworks in broader
literature.
3) Qualitative research to understand modellers’ experiences
with developing the structure of PH economic models &
their views about the benefits/ barriers of using a CM
framework.
4) Pilot of the draft CM framework within a case study of
diabetes screening & prevention.
5) Evaluation via qualitative analysis & theory-based
evaluation.
Squires H, Chilcott J, Akehurst R, Burr J, Kelly M. A systematic literature review of the key challenges for developing the
structure of public health economic models. Int. J. of Public Health. Epub ahead of print.
http://www.ncbi.nlm.nih.gov/pubmed/26747470
The CM framework:
Key principles
(1) A systems approach to Public Health modelling should
be taken (feedback loops & unintended consequences
are important);
(2) Developing a thorough documented understanding of
the problem is imperative prior to and alongside
developing and justifying the model structure;
(3) Strong communication with stakeholders and members
of the team throughout model development is essential;
(4) A systematic consideration of the determinants of health
is central to identifying all key impacts of the
interventions within Public Health economic modelling.
A systems approach
The CM framework:
Key principles
(1) A systems approach to Public Health modelling should
be taken (feedback loops & unintended consequences
are important);
(2) Developing a thorough documented understanding of
the problem is imperative prior to and alongside
developing and justifying the model structure;
(3) Strong communication with stakeholders and members
of the team throughout model development is essential;
(4) A systematic consideration of the determinants of health
is central to identifying all key impacts of the
interventions within Public Health economic modelling.
The CM framework:
Key principles
(1) A systems approach to Public Health modelling should
be taken (feedback loops & unintended consequences
are important);
(2) Developing a thorough documented understanding of
the problem is imperative prior to and alongside
developing and justifying the model structure;
(3) Strong communication with stakeholders and members
of the team throughout model development is essential;
(4) A systematic consideration of the determinants of health
is central to identifying all key impacts of the
interventions within Public Health economic modelling.
The CM framework:
Key principles
(1) A systems approach to Public Health modelling should
be taken (feedback loops & unintended consequences
are important);
(2) Developing a thorough documented understanding of
the problem is imperative prior to and alongside
developing and justifying the model structure;
(3) Strong communication with stakeholders and members
of the team throughout model development is essential;
(4) A systematic consideration of the determinants of health
is central to identifying all key impacts of the
interventions within Public Health economic modelling.
The determinants of health
Dahlgren G., Whitehead M. Policies and strategies to promote social equity in health. 1991. Institute
for Future Studies, Stockholm.
CM framework overview
Aligning the framework with
the decision making process
Identifying relevant
stakeholders
Understanding the problem
i) Developing a conceptual model of the problem
ii) Establishing resource pathways
Developing and justifying the model structure
i) Reviewing existing economic evaluations
ii) Choosing specific model interventions
iii) Determining the model boundary
iv) Determining the level of detail
v) Choosing the model type
vi) Developing a qualitative description of the quantitative model
CM framework overview
Aligning the framework with
the decision making process
Identifying relevant
stakeholders
Understanding the problem
i) Developing a conceptual model of the problem
ii) Establishing resource pathways
Developing and justifying the model structure
i) Reviewing existing economic evaluations
ii) Choosing specific model interventions
iii) Determining the model boundary
iv) Determining the level of detail
v) Choosing the model type
vi) Developing a qualitative description of the quantitative model
CM framework overview
Aligning the framework with
the decision making process
Identifying relevant
stakeholders
Understanding the problem
i) Developing a conceptual model of the problem
ii) Establishing resource pathways
Developing and justifying the model structure
i) Reviewing existing economic evaluations
ii) Choosing specific model interventions
iii) Determining the model boundary
iv) Determining the level of detail
v) Choosing the model type
vi) Developing a qualitative description of the quantitative model
Stakeholders
Stakeholders are identified based upon the
classification from Soft Systems Methodology
(SSM):
• Customers which might include patient
representatives and lay members;
• Actors which might include clinical experts and
epidemiologic experts for all relevant diseases
and methods experts;
• System owners which might include policy
experts (in addition to some of the people
identified as actors).
CM framework overview
Aligning the framework with
the decision making process
Identifying relevant
stakeholders
Understanding the problem
i) Developing a conceptual model of the problem
ii) Establishing resource pathways
Developing and justifying the model structure
i) Reviewing existing economic evaluations
ii) Choosing specific model interventions
iii) Determining the model boundary
iv) Determining the level of detail
v) Choosing the model type
vi) Developing a qualitative description of the quantitative model
Example conceptual
model of the problem
Contraception project example:
Why is this a problem?
_ _
Maximise health Minimise costs to NHS & PSS Minimise costs to other sectors
_ _ _ _ _ _ _ _ _
Poor health outcomes of the mother
Low birth weight babies + Poor long term socioeconomic outcomes
+ + +
Miscarriage/ stillbirth Abortion Unwanted teenage birth
+ + +
What is the problem? +
Unintended teenage pregnancies STIs
_ + +
Poor contraceptive use by sexually active teenagers
(interaction between a male & female)
+ +
Disadvantaged background
Competing risks
Dependent on history & timing of STIs
Questions to help develop
diagram: The disease &
determinants of health
• Have any relevant disease natural histories been
captured?
• Are the following determinants of health important in
determining outcomes & in what way:
• Age, sex & other inherent characteristics of the population of
interest?
• Individual lifestyle factors?
• Social and community networks?
• Living & working conditions & access to essential goods &
services?
• General socioeconomic, cultural & environmental conditions?
Questions to help develop
diagram: Dynamic complexity
• Are there any other (positive or negative)
consequences of each concept?
• Are there any other possible causal links
between the factors? (to establish whether there
are any feedback loops)
• Could there be any other factors which explain
both of these outcomes, for links which may not
be causal, but correlated?
• Are there interactions between different sets of
people?
• Is timing/ ordering of events important?
Questions to help develop
diagram: Intervention outcomes
• What is a good outcome?
• What would happen in the absence of the
interventions versus as a result of the interventions
– would behaviour be prevented or delayed?
• What evidence exists to describe the outcomes of
the intervention/ comparator over time? Are
behavioural outcomes important?
• Are there any determinants of health reported by
the effectiveness studies which are not included
within the causal diagram? Can such a relationship
be described?
Questions to help develop
diagram: Dynamic complexity
of interventions
• Might a third party act to reduce or increase the
impact of interventions?
• Are there any substantial impacts of social and/or
community networks upon intervention
effectiveness? Will these impacts be captured over
the long term within the effectiveness evidence?
• Are there any substantial impacts of the
interventions upon other lifestyle factors?
• Might the interventions have other impacts not
already considered?
Sources of evidence
Starting with high
yield sources
Individual stakeholder
assumptions & beliefs
Stakeholder
discussion
Modeller assumptions
& beliefs
Project scope
Literature
sources
Existing diagrams/
previous work
Conceptual model of the problem
CM framework overview
Aligning the framework with
the decision making process
Identifying relevant
stakeholders
Understanding the problem
i) Developing a conceptual model of the problem
ii) Establishing resource pathways
Developing and justifying the model structure
i) Reviewing existing economic evaluations
ii) Choosing specific model interventions
iii) Determining the model boundary
iv) Determining the level of detail
v) Choosing the model type
vi) Developing a qualitative description of the quantitative model
CM framework overview
Aligning the framework with
the decision making process
Identifying relevant
stakeholders
Understanding the problem
i) Developing a conceptual model of the problem
ii) Establishing resource pathways
Developing and justifying the model structure
i) Reviewing existing economic evaluations
ii) Choosing specific model interventions
iii) Determining the model boundary
iv) Determining the level of detail
v) Choosing the model type
vi) Developing a qualitative description of the quantitative model
Develop understanding of the
problem
Assess whether there is
an existing model which
could be employed
Identify strengths &
limitations of different
model structures
Identify strengths &
limitations of different
model types
Identify key variables which
generally affect model results
(incl. any not already
identified) & key variables
included within the causal
diagram which do not
Identify the sort
of data available
Identify factors with not many
causal links & assess whether
they would have a substantial
impact upon the difference
between outcomes of
interventions & comparators
Identify types of
outcomes reported
Identify long term
evidence & mechanisms
Describe effectiveness of
interventions (to help
choose which to model
& for parameterisation)
Model boundary Model detail Model type
Discuss potential model perspectives,
outcomes, interventions &
populations with stakeholders
Review existing health
economic models
Review effectiveness of
relevant interventions
Review evidence of
relationships between factors
Does the factor have many causal links?
Yes No
Is the factor likely to have a substantial
impact upon the difference between costs &
effects of the interventions? This may be
based upon (though not limited to):
(1) the review of economic evaluations;
(2) the description of resource pathways;
(3) clinical papers describing the causal links;
(4) existing models in similar areas which
describe the impact of the factor;
(5) methodological choices eg. discounting;
(6) expert advice.
Yes No
INCLUDE
Is the factor associated with the interventions,
populations & outcomes being modelled?
EXCLUDE
INCLUDE
EXCLUDE
Yes No
Yes
Is the impact of the factor predominantly
captured by other included factors?
Yes
EXCLUDE
No
Would stakeholders prefer to
include the factor for model
credibility AND is it relatively easy
to incorporate in terms of
modelling skill & data availability?
INCLUDE
No
Will the model only assess one intervention AND
is the intervention likely to be cost-effective AND
does the factor only further increase benefits
Yes
No
Determining
the model
boundary
A systems approach
Determining level of detail
Key types of model assumptions/ simplifications:
1. The relationship between the included factors over time;
2. The extrapolation of study outcomes;
3. The level of detail used to describe each included factor;
4. How interventions will be implemented in practice.
Questions to help the modeller for each of these are
proposed within the framework.
Choosing model type (1)
A B C D
Cohort/ aggregate level/ counts Individual level
Expected value,
continuous state,
deterministic
Markovian, discrete
state, stochastic
Markovian, discrete
state
Non-Markovian,
discrete state
1 No
interaction
Untimed Decision tree
rollback
Simulation decision
tree
Individual sampling model: Simulated
patient-level decision tree
2 Timed Markov model
(deterministic)
Simulation Markov
model
Individual sampling model: Simulated
patient-level Markov model
3 Interaction
between
entity and
environment
Discrete
time
System dynamics
(finite difference
equations)
Discrete time
Markov chain
model
Discrete-time
individual event
history model
Discrete individual
simulation
4 Continuous
time
System dynamics
(ordinary
differential
equations)
Continuous time
Markov chain
model
Continuous time
individual event
history model
Discrete event
simulation
5 Strong interactions
between entities. Spatial
aspects important.
X X X Agent-based
simulation
Revised version of taxonomy by Brennan A, Chick SE, Davies R. A taxonomy of model structures
for economic evaluation of health technologies. Health Econ 2006; 15(12):1295-1310.
Choosing
model type
(2)
Determine the most appropriate model type for the characteristics of the problem.
Is this feasible within the time and resource constraints of the decision making process given:
(i) the data available?
AND
(ii) the accessibility of any existing relevant good quality economic evaluations for use as
a starting point?
AND
(iii) the expertise of the modeller?
Are you intending to use the
model again for other
projects?
Can you answer the decision makers’ question
with a few provisos and uncertainties with a
simpler model type?
Yes No
Explore with the
decision maker the
most useful purpose of
the modelling given the
project constraints
Develop the simpler model
type, documenting the
provisos, uncertainties &
implications of the
simplifications
NoYes
Do you think a
simpler model type
would lead to the
same conclusions?
Develop
the
model
Yes No
Develop the more
complex model
Develop the simpler model,
documenting the provisos,
uncertainties & implications
of the simplifications
Yes No
Conclusions
• Very little research has been undertaken
around conceptual modelling in health
economic evaluation.
• We have developed a conceptual modelling
framework for use within Public Health
economic models (paper under review).
• This has yet to be tested on a range of case
studies.
• If anybody wants to know more about the
framework or potentially use it, let me know!
Email: h.squires@sheffield.ac.uk
PhD thesis: http://etheses.whiterose.ac.uk/5316/

More Related Content

What's hot

Health economics
Health economicsHealth economics
Health economics
Devangi Sharma
 
Health economics
Health economicsHealth economics
Health economics
ancychacko89
 
Health economics an overview
Health economics an overviewHealth economics an overview
Health economics an overview
Abdur Razzaque Sarker, PhD
 
Introduction to Health Economics
Introduction to Health EconomicsIntroduction to Health Economics
Introduction to Health Economics
Josep Vidal-Alaball
 
Health economics in nursing
Health economics in nursingHealth economics in nursing
Health economics in nursing
M MELVIN DAVID
 
Health economics
Health economicsHealth economics
Health economics
Barath Babu Kumar
 
Health Economics
Health EconomicsHealth Economics
Health Economics
Sharon Treesa Antony
 
Health economics
Health economicsHealth economics
Health economics
Nabin Lamichhane
 
Health economics
Health economicsHealth economics
Health economics
Amit Pagada
 
Health economics
Health economics Health economics
Health economics taparia49
 
Health Economics and Health Finance :Jordan Health Policy Directions
Health Economics  and Health Finance  :Jordan Health Policy Directions   Health Economics  and Health Finance  :Jordan Health Policy Directions
Health Economics and Health Finance :Jordan Health Policy Directions
Musa Ajlouni
 
Health economics basics
Health economics basics Health economics basics
Health economics basics
BPKIHS
 
Basics of Health economics
Basics of Health economicsBasics of Health economics
Basics of Health economics
sourav goswami
 
Translational Genomics_Health economic evaluation
Translational Genomics_Health economic evaluationTranslational Genomics_Health economic evaluation
Translational Genomics_Health economic evaluationKirsten van Nimwegen
 
13 . health economics .........
13 . health economics .........13 . health economics .........
13 . health economics .........
abcde123321
 
Health Economics
Health EconomicsHealth Economics
Health Economics
Prabha Panth
 
Health economics
Health economics Health economics
Health economics
NAVANEETA KUSUM
 
Economic Evaluation in Healthcare
Economic Evaluation in HealthcareEconomic Evaluation in Healthcare
Economic Evaluation in Healthcare
DRRV
 
Health economics what is it
Health economics what is itHealth economics what is it
Health economics what is it
Dr (Gp Capt) S Mankar
 

What's hot (20)

Health economics
Health economicsHealth economics
Health economics
 
Health economics
Health economicsHealth economics
Health economics
 
Health economics an overview
Health economics an overviewHealth economics an overview
Health economics an overview
 
Introduction to Health Economics
Introduction to Health EconomicsIntroduction to Health Economics
Introduction to Health Economics
 
Health economics in nursing
Health economics in nursingHealth economics in nursing
Health economics in nursing
 
Health economics
Health economicsHealth economics
Health economics
 
Health economics
Health economicsHealth economics
Health economics
 
Health Economics
Health EconomicsHealth Economics
Health Economics
 
Health economics
Health economicsHealth economics
Health economics
 
Health economics
Health economicsHealth economics
Health economics
 
Health economics
Health economics Health economics
Health economics
 
Health Economics and Health Finance :Jordan Health Policy Directions
Health Economics  and Health Finance  :Jordan Health Policy Directions   Health Economics  and Health Finance  :Jordan Health Policy Directions
Health Economics and Health Finance :Jordan Health Policy Directions
 
Health economics basics
Health economics basics Health economics basics
Health economics basics
 
Basics of Health economics
Basics of Health economicsBasics of Health economics
Basics of Health economics
 
Translational Genomics_Health economic evaluation
Translational Genomics_Health economic evaluationTranslational Genomics_Health economic evaluation
Translational Genomics_Health economic evaluation
 
13 . health economics .........
13 . health economics .........13 . health economics .........
13 . health economics .........
 
Health Economics
Health EconomicsHealth Economics
Health Economics
 
Health economics
Health economics Health economics
Health economics
 
Economic Evaluation in Healthcare
Economic Evaluation in HealthcareEconomic Evaluation in Healthcare
Economic Evaluation in Healthcare
 
Health economics what is it
Health economics what is itHealth economics what is it
Health economics what is it
 

Viewers also liked

: Viable Systemic Approach to a National Health Service Organization Process ...
: Viable Systemic Approach to a National Health Service Organization Process ...: Viable Systemic Approach to a National Health Service Organization Process ...
: Viable Systemic Approach to a National Health Service Organization Process ...
Alexandros Miaris
 
Health economic modelling in the diagnostics development process
Health economic modelling in the diagnostics development processHealth economic modelling in the diagnostics development process
Health economic modelling in the diagnostics development process
cheweb1
 
Health economic modelling in bowel cancer
Health economic modelling in bowel cancerHealth economic modelling in bowel cancer
Health economic modelling in bowel cancerScHARR HEDS
 
Introduction to Complex Health Systems: wrap-up
Introduction to Complex Health Systems: wrap-up Introduction to Complex Health Systems: wrap-up
Introduction to Complex Health Systems: wrap-up
Collaboration for Health Policy & Systems Analysis in Africa (CHEPSAA)
 
Katmandu
KatmanduKatmandu
Katmandu2M2
 
Bayesian multivariate meta-analysis for modelling surrogate endpoints in HTA
Bayesian multivariate meta-analysis for modelling surrogate endpoints in HTABayesian multivariate meta-analysis for modelling surrogate endpoints in HTA
Bayesian multivariate meta-analysis for modelling surrogate endpoints in HTA
cheweb1
 
A Systematic Approach to the Planning, Implementation, Monitoring, and Evalua...
A Systematic Approach to the Planning, Implementation, Monitoring, and Evalua...A Systematic Approach to the Planning, Implementation, Monitoring, and Evalua...
A Systematic Approach to the Planning, Implementation, Monitoring, and Evalua...
MEASURE Evaluation
 
The life and experience of a health system: considering political economy
The life and experience of a health system: considering political economyThe life and experience of a health system: considering political economy
The life and experience of a health system: considering political economy
Collaboration for Health Policy & Systems Analysis in Africa (CHEPSAA)
 
Asia's Quiet War on Lung Cancer
Asia's Quiet War on Lung CancerAsia's Quiet War on Lung Cancer
Asia's Quiet War on Lung Cancer
Eden Strategy Institute LLP
 
Types of learners
Types of learnersTypes of learners
Types of learners
NerminNadir
 
The Power of Learning Through Doing
The Power of Learning Through DoingThe Power of Learning Through Doing
The Power of Learning Through Doing
Sophie Mills
 
An Introduction to Health Economics
An Introduction to Health EconomicsAn Introduction to Health Economics
An Introduction to Health Economics
Pharmacy @ Institut Kanser Negara
 
Environmental Health:Economic Costs of Environmental Damage And Suggested Pri...
Environmental Health:Economic Costs of Environmental Damage And Suggested Pri...Environmental Health:Economic Costs of Environmental Damage And Suggested Pri...
Environmental Health:Economic Costs of Environmental Damage And Suggested Pri...
No to mining in Palawan
 
Decision-analytic Modeling for Clinical and Economic Projections
Decision-analytic Modeling for Clinical and Economic ProjectionsDecision-analytic Modeling for Clinical and Economic Projections
Decision-analytic Modeling for Clinical and Economic Projections
Harvard Medical School, LMU Munich
 
Approaches to Evaluating New Medicines in France, Germany and England
Approaches to Evaluating New Medicines in France, Germany and EnglandApproaches to Evaluating New Medicines in France, Germany and England
Approaches to Evaluating New Medicines in France, Germany and England
Office of Health Economics
 
TYPES COST
 TYPES COST  TYPES COST
TYPES COST
Babasab Patil
 
Oncopharmacoeconomy ii, Prof. Dr. F. Cankat Tulunay
Oncopharmacoeconomy ii, Prof. Dr. F. Cankat TulunayOncopharmacoeconomy ii, Prof. Dr. F. Cankat Tulunay
Oncopharmacoeconomy ii, Prof. Dr. F. Cankat Tulunay
F. Cankat Tulunay
 
Topic 6 stat probability theory
Topic 6 stat probability theoryTopic 6 stat probability theory
Topic 6 stat probability theorySizwan Ahammed
 
Cost Accounting
Cost AccountingCost Accounting
Cost Accounting
Ketan Rai
 

Viewers also liked (20)

: Viable Systemic Approach to a National Health Service Organization Process ...
: Viable Systemic Approach to a National Health Service Organization Process ...: Viable Systemic Approach to a National Health Service Organization Process ...
: Viable Systemic Approach to a National Health Service Organization Process ...
 
Health economic modelling in the diagnostics development process
Health economic modelling in the diagnostics development processHealth economic modelling in the diagnostics development process
Health economic modelling in the diagnostics development process
 
Health economic modelling in bowel cancer
Health economic modelling in bowel cancerHealth economic modelling in bowel cancer
Health economic modelling in bowel cancer
 
Introduction to Complex Health Systems: wrap-up
Introduction to Complex Health Systems: wrap-up Introduction to Complex Health Systems: wrap-up
Introduction to Complex Health Systems: wrap-up
 
Katmandu
KatmanduKatmandu
Katmandu
 
Bayesian multivariate meta-analysis for modelling surrogate endpoints in HTA
Bayesian multivariate meta-analysis for modelling surrogate endpoints in HTABayesian multivariate meta-analysis for modelling surrogate endpoints in HTA
Bayesian multivariate meta-analysis for modelling surrogate endpoints in HTA
 
A Systematic Approach to the Planning, Implementation, Monitoring, and Evalua...
A Systematic Approach to the Planning, Implementation, Monitoring, and Evalua...A Systematic Approach to the Planning, Implementation, Monitoring, and Evalua...
A Systematic Approach to the Planning, Implementation, Monitoring, and Evalua...
 
The life and experience of a health system: considering political economy
The life and experience of a health system: considering political economyThe life and experience of a health system: considering political economy
The life and experience of a health system: considering political economy
 
Asia's Quiet War on Lung Cancer
Asia's Quiet War on Lung CancerAsia's Quiet War on Lung Cancer
Asia's Quiet War on Lung Cancer
 
Types of learners
Types of learnersTypes of learners
Types of learners
 
The Power of Learning Through Doing
The Power of Learning Through DoingThe Power of Learning Through Doing
The Power of Learning Through Doing
 
An Introduction to Health Economics
An Introduction to Health EconomicsAn Introduction to Health Economics
An Introduction to Health Economics
 
Sigma xi presentation
Sigma xi presentationSigma xi presentation
Sigma xi presentation
 
Environmental Health:Economic Costs of Environmental Damage And Suggested Pri...
Environmental Health:Economic Costs of Environmental Damage And Suggested Pri...Environmental Health:Economic Costs of Environmental Damage And Suggested Pri...
Environmental Health:Economic Costs of Environmental Damage And Suggested Pri...
 
Decision-analytic Modeling for Clinical and Economic Projections
Decision-analytic Modeling for Clinical and Economic ProjectionsDecision-analytic Modeling for Clinical and Economic Projections
Decision-analytic Modeling for Clinical and Economic Projections
 
Approaches to Evaluating New Medicines in France, Germany and England
Approaches to Evaluating New Medicines in France, Germany and EnglandApproaches to Evaluating New Medicines in France, Germany and England
Approaches to Evaluating New Medicines in France, Germany and England
 
TYPES COST
 TYPES COST  TYPES COST
TYPES COST
 
Oncopharmacoeconomy ii, Prof. Dr. F. Cankat Tulunay
Oncopharmacoeconomy ii, Prof. Dr. F. Cankat TulunayOncopharmacoeconomy ii, Prof. Dr. F. Cankat Tulunay
Oncopharmacoeconomy ii, Prof. Dr. F. Cankat Tulunay
 
Topic 6 stat probability theory
Topic 6 stat probability theoryTopic 6 stat probability theory
Topic 6 stat probability theory
 
Cost Accounting
Cost AccountingCost Accounting
Cost Accounting
 

Similar to A methodological framework for developing the structure of Public Health economic models

Structured decision making approaches to the inclusion of multiple criteria i...
Structured decision making approaches to the inclusion of multiple criteria i...Structured decision making approaches to the inclusion of multiple criteria i...
Structured decision making approaches to the inclusion of multiple criteria i...
Office of Health Economics
 
Looking at implementation: how useful is realist evaluation?
Looking at implementation: how useful is realist evaluation?Looking at implementation: how useful is realist evaluation?
Looking at implementation: how useful is realist evaluation?
valéry ridde
 
BRAINPOoL Workshop 24 March 2014: E-frame presentation
BRAINPOoL Workshop 24 March 2014: E-frame presentationBRAINPOoL Workshop 24 March 2014: E-frame presentation
BRAINPOoL Workshop 24 March 2014: E-frame presentationnefwellbeing
 
Improving Our Capacity to Develop Capacity in Health_Dr. Leonardo Cubillos Tu...
Improving Our Capacity to Develop Capacity in Health_Dr. Leonardo Cubillos Tu...Improving Our Capacity to Develop Capacity in Health_Dr. Leonardo Cubillos Tu...
Improving Our Capacity to Develop Capacity in Health_Dr. Leonardo Cubillos Tu...CORE Group
 
communityhealthnursing.pptx
communityhealthnursing.pptxcommunityhealthnursing.pptx
communityhealthnursing.pptx
MuzammilKhan945443
 
Health system strengthening – what is it, how should we assess it, and does i...
Health system strengthening – what is it, how should we assess it, and does i...Health system strengthening – what is it, how should we assess it, and does i...
Health system strengthening – what is it, how should we assess it, and does i...
ReBUILD for Resilience
 
Evidence on Improving Health Service Delivery in Developing Countries
Evidence on Improving Health Service Delivery in Developing CountriesEvidence on Improving Health Service Delivery in Developing Countries
Evidence on Improving Health Service Delivery in Developing Countries
IDS
 
HCM 3305, Community Health 1 Course Learning Outcom.docx
 HCM 3305, Community Health 1 Course Learning Outcom.docx HCM 3305, Community Health 1 Course Learning Outcom.docx
HCM 3305, Community Health 1 Course Learning Outcom.docx
aryan532920
 
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
Office of Health Economics
 
Pateint safety bonafide administration
Pateint safety bonafide administrationPateint safety bonafide administration
Pateint safety bonafide administration
Latha Venkatesan
 
Suzanne Wait: Does benchmarking guide policy
Suzanne Wait: Does benchmarking guide policySuzanne Wait: Does benchmarking guide policy
Suzanne Wait: Does benchmarking guide policyNuffield Trust
 
policy review
policy reviewpolicy review
policy review
RamprasathJayabalan1
 
NCCMT Webinar - Contextualizing Guidelines Workbook
NCCMT Webinar - Contextualizing Guidelines WorkbookNCCMT Webinar - Contextualizing Guidelines Workbook
NCCMT Webinar - Contextualizing Guidelines Workbook
The National Collaborating Centre for Methods and Tools
 
Composit indicator.pdf
Composit indicator.pdfComposit indicator.pdf
Composit indicator.pdf
AlexAlex401238
 
ppt presentation.docx
ppt presentation.docxppt presentation.docx
ppt presentation.docx
write31
 
ppt presentation.docx
ppt presentation.docxppt presentation.docx
ppt presentation.docx
bkbk37
 
Can systematic reviews help identify what works and why?
Can systematic reviews help identify what works and why?Can systematic reviews help identify what works and why?
Can systematic reviews help identify what works and why?
Carina van Rooyen
 
· Justify the value of marketing plans as instruments that compel .docx
· Justify the value of marketing plans as instruments that compel .docx· Justify the value of marketing plans as instruments that compel .docx
· Justify the value of marketing plans as instruments that compel .docx
oswald1horne84988
 
Amia 00 Curriculum Presentation
Amia 00 Curriculum PresentationAmia 00 Curriculum Presentation
Amia 00 Curriculum Presentationbrighteyes
 
Selected references on managing change 8 30
Selected references on managing change  8 30Selected references on managing change  8 30
Selected references on managing change 8 30
Saide OER Africa
 

Similar to A methodological framework for developing the structure of Public Health economic models (20)

Structured decision making approaches to the inclusion of multiple criteria i...
Structured decision making approaches to the inclusion of multiple criteria i...Structured decision making approaches to the inclusion of multiple criteria i...
Structured decision making approaches to the inclusion of multiple criteria i...
 
Looking at implementation: how useful is realist evaluation?
Looking at implementation: how useful is realist evaluation?Looking at implementation: how useful is realist evaluation?
Looking at implementation: how useful is realist evaluation?
 
BRAINPOoL Workshop 24 March 2014: E-frame presentation
BRAINPOoL Workshop 24 March 2014: E-frame presentationBRAINPOoL Workshop 24 March 2014: E-frame presentation
BRAINPOoL Workshop 24 March 2014: E-frame presentation
 
Improving Our Capacity to Develop Capacity in Health_Dr. Leonardo Cubillos Tu...
Improving Our Capacity to Develop Capacity in Health_Dr. Leonardo Cubillos Tu...Improving Our Capacity to Develop Capacity in Health_Dr. Leonardo Cubillos Tu...
Improving Our Capacity to Develop Capacity in Health_Dr. Leonardo Cubillos Tu...
 
communityhealthnursing.pptx
communityhealthnursing.pptxcommunityhealthnursing.pptx
communityhealthnursing.pptx
 
Health system strengthening – what is it, how should we assess it, and does i...
Health system strengthening – what is it, how should we assess it, and does i...Health system strengthening – what is it, how should we assess it, and does i...
Health system strengthening – what is it, how should we assess it, and does i...
 
Evidence on Improving Health Service Delivery in Developing Countries
Evidence on Improving Health Service Delivery in Developing CountriesEvidence on Improving Health Service Delivery in Developing Countries
Evidence on Improving Health Service Delivery in Developing Countries
 
HCM 3305, Community Health 1 Course Learning Outcom.docx
 HCM 3305, Community Health 1 Course Learning Outcom.docx HCM 3305, Community Health 1 Course Learning Outcom.docx
HCM 3305, Community Health 1 Course Learning Outcom.docx
 
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
 
Pateint safety bonafide administration
Pateint safety bonafide administrationPateint safety bonafide administration
Pateint safety bonafide administration
 
Suzanne Wait: Does benchmarking guide policy
Suzanne Wait: Does benchmarking guide policySuzanne Wait: Does benchmarking guide policy
Suzanne Wait: Does benchmarking guide policy
 
policy review
policy reviewpolicy review
policy review
 
NCCMT Webinar - Contextualizing Guidelines Workbook
NCCMT Webinar - Contextualizing Guidelines WorkbookNCCMT Webinar - Contextualizing Guidelines Workbook
NCCMT Webinar - Contextualizing Guidelines Workbook
 
Composit indicator.pdf
Composit indicator.pdfComposit indicator.pdf
Composit indicator.pdf
 
ppt presentation.docx
ppt presentation.docxppt presentation.docx
ppt presentation.docx
 
ppt presentation.docx
ppt presentation.docxppt presentation.docx
ppt presentation.docx
 
Can systematic reviews help identify what works and why?
Can systematic reviews help identify what works and why?Can systematic reviews help identify what works and why?
Can systematic reviews help identify what works and why?
 
· Justify the value of marketing plans as instruments that compel .docx
· Justify the value of marketing plans as instruments that compel .docx· Justify the value of marketing plans as instruments that compel .docx
· Justify the value of marketing plans as instruments that compel .docx
 
Amia 00 Curriculum Presentation
Amia 00 Curriculum PresentationAmia 00 Curriculum Presentation
Amia 00 Curriculum Presentation
 
Selected references on managing change 8 30
Selected references on managing change  8 30Selected references on managing change  8 30
Selected references on managing change 8 30
 

More from cheweb1

The value of Value of Information (VoI): When and how to use simpler or heuri...
The value of Value of Information (VoI): When and how to use simpler or heuri...The value of Value of Information (VoI): When and how to use simpler or heuri...
The value of Value of Information (VoI): When and how to use simpler or heuri...
cheweb1
 
Dynamic survival models for predicting the future in health technology assess...
Dynamic survival models for predicting the future in health technology assess...Dynamic survival models for predicting the future in health technology assess...
Dynamic survival models for predicting the future in health technology assess...
cheweb1
 
Withinfamily che presentation_200609
Withinfamily che presentation_200609Withinfamily che presentation_200609
Withinfamily che presentation_200609
cheweb1
 
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
cheweb1
 
Valuation in health economics: Reflections of a UK health economist… and patient
Valuation in health economics: Reflections of a UK health economist… and patientValuation in health economics: Reflections of a UK health economist… and patient
Valuation in health economics: Reflections of a UK health economist… and patient
cheweb1
 
Health Research Authority Approval: Information for Sponsors
Health Research Authority Approval: Information for SponsorsHealth Research Authority Approval: Information for Sponsors
Health Research Authority Approval: Information for Sponsors
cheweb1
 
Modeling the cost effectiveness of two big league pay-for-performance policies
Modeling the cost effectiveness of two big league pay-for-performance policiesModeling the cost effectiveness of two big league pay-for-performance policies
Modeling the cost effectiveness of two big league pay-for-performance policies
cheweb1
 
Baker what to do when people disagree che york seminar jan 2019 v2
Baker what to do when people disagree che york seminar jan 2019 v2Baker what to do when people disagree che york seminar jan 2019 v2
Baker what to do when people disagree che york seminar jan 2019 v2
cheweb1
 
The longest-lasting, most popular, and yet most thoroughly discredited idea i...
The longest-lasting, most popular, and yet most thoroughly discredited idea i...The longest-lasting, most popular, and yet most thoroughly discredited idea i...
The longest-lasting, most popular, and yet most thoroughly discredited idea i...
cheweb1
 
Cost-effectiveness of diagnosis: tests, pay-offs and uncertainties
Cost-effectiveness of diagnosis: tests, pay-offs and uncertaintiesCost-effectiveness of diagnosis: tests, pay-offs and uncertainties
Cost-effectiveness of diagnosis: tests, pay-offs and uncertainties
cheweb1
 
Insights from actuarial science into HTA: Building joint models of random qua...
Insights from actuarial science into HTA: Building joint models of random qua...Insights from actuarial science into HTA: Building joint models of random qua...
Insights from actuarial science into HTA: Building joint models of random qua...
cheweb1
 
The implications of parameter independence in probabilistic sensitivity analy...
The implications of parameter independence in probabilistic sensitivity analy...The implications of parameter independence in probabilistic sensitivity analy...
The implications of parameter independence in probabilistic sensitivity analy...
cheweb1
 
Adjusting for treatment switching in randomised controlled trials
Adjusting for treatment switching in randomised controlled trialsAdjusting for treatment switching in randomised controlled trials
Adjusting for treatment switching in randomised controlled trials
cheweb1
 
Discounting future healthcare costs and benefits (part 2)
Discounting future healthcare costs and benefits (part 2)Discounting future healthcare costs and benefits (part 2)
Discounting future healthcare costs and benefits (part 2)
cheweb1
 
Discounting future healthcare costs and benefits(Part 1)
Discounting future healthcare costs and benefits(Part 1)Discounting future healthcare costs and benefits(Part 1)
Discounting future healthcare costs and benefits(Part 1)
cheweb1
 
The reference ICER for the Australian health system: estimation and barriers ...
The reference ICER for the Australian health system: estimation and barriers ...The reference ICER for the Australian health system: estimation and barriers ...
The reference ICER for the Australian health system: estimation and barriers ...
cheweb1
 
Valuing paediatric preference-based measures: using a discrete choice experim...
Valuing paediatric preference-based measures: using a discrete choice experim...Valuing paediatric preference-based measures: using a discrete choice experim...
Valuing paediatric preference-based measures: using a discrete choice experim...
cheweb1
 
Does transfer to intensive care units reduce mortality for deteriorating ward...
Does transfer to intensive care units reduce mortality for deteriorating ward...Does transfer to intensive care units reduce mortality for deteriorating ward...
Does transfer to intensive care units reduce mortality for deteriorating ward...
cheweb1
 
Economic evaluation of changes to the organisation and delivery of health ser...
Economic evaluation of changes to the organisation and delivery of health ser...Economic evaluation of changes to the organisation and delivery of health ser...
Economic evaluation of changes to the organisation and delivery of health ser...
cheweb1
 
Quantifying the added societal value of public health interventions in reduci...
Quantifying the added societal value of public health interventions in reduci...Quantifying the added societal value of public health interventions in reduci...
Quantifying the added societal value of public health interventions in reduci...
cheweb1
 

More from cheweb1 (20)

The value of Value of Information (VoI): When and how to use simpler or heuri...
The value of Value of Information (VoI): When and how to use simpler or heuri...The value of Value of Information (VoI): When and how to use simpler or heuri...
The value of Value of Information (VoI): When and how to use simpler or heuri...
 
Dynamic survival models for predicting the future in health technology assess...
Dynamic survival models for predicting the future in health technology assess...Dynamic survival models for predicting the future in health technology assess...
Dynamic survival models for predicting the future in health technology assess...
 
Withinfamily che presentation_200609
Withinfamily che presentation_200609Withinfamily che presentation_200609
Withinfamily che presentation_200609
 
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
 
Valuation in health economics: Reflections of a UK health economist… and patient
Valuation in health economics: Reflections of a UK health economist… and patientValuation in health economics: Reflections of a UK health economist… and patient
Valuation in health economics: Reflections of a UK health economist… and patient
 
Health Research Authority Approval: Information for Sponsors
Health Research Authority Approval: Information for SponsorsHealth Research Authority Approval: Information for Sponsors
Health Research Authority Approval: Information for Sponsors
 
Modeling the cost effectiveness of two big league pay-for-performance policies
Modeling the cost effectiveness of two big league pay-for-performance policiesModeling the cost effectiveness of two big league pay-for-performance policies
Modeling the cost effectiveness of two big league pay-for-performance policies
 
Baker what to do when people disagree che york seminar jan 2019 v2
Baker what to do when people disagree che york seminar jan 2019 v2Baker what to do when people disagree che york seminar jan 2019 v2
Baker what to do when people disagree che york seminar jan 2019 v2
 
The longest-lasting, most popular, and yet most thoroughly discredited idea i...
The longest-lasting, most popular, and yet most thoroughly discredited idea i...The longest-lasting, most popular, and yet most thoroughly discredited idea i...
The longest-lasting, most popular, and yet most thoroughly discredited idea i...
 
Cost-effectiveness of diagnosis: tests, pay-offs and uncertainties
Cost-effectiveness of diagnosis: tests, pay-offs and uncertaintiesCost-effectiveness of diagnosis: tests, pay-offs and uncertainties
Cost-effectiveness of diagnosis: tests, pay-offs and uncertainties
 
Insights from actuarial science into HTA: Building joint models of random qua...
Insights from actuarial science into HTA: Building joint models of random qua...Insights from actuarial science into HTA: Building joint models of random qua...
Insights from actuarial science into HTA: Building joint models of random qua...
 
The implications of parameter independence in probabilistic sensitivity analy...
The implications of parameter independence in probabilistic sensitivity analy...The implications of parameter independence in probabilistic sensitivity analy...
The implications of parameter independence in probabilistic sensitivity analy...
 
Adjusting for treatment switching in randomised controlled trials
Adjusting for treatment switching in randomised controlled trialsAdjusting for treatment switching in randomised controlled trials
Adjusting for treatment switching in randomised controlled trials
 
Discounting future healthcare costs and benefits (part 2)
Discounting future healthcare costs and benefits (part 2)Discounting future healthcare costs and benefits (part 2)
Discounting future healthcare costs and benefits (part 2)
 
Discounting future healthcare costs and benefits(Part 1)
Discounting future healthcare costs and benefits(Part 1)Discounting future healthcare costs and benefits(Part 1)
Discounting future healthcare costs and benefits(Part 1)
 
The reference ICER for the Australian health system: estimation and barriers ...
The reference ICER for the Australian health system: estimation and barriers ...The reference ICER for the Australian health system: estimation and barriers ...
The reference ICER for the Australian health system: estimation and barriers ...
 
Valuing paediatric preference-based measures: using a discrete choice experim...
Valuing paediatric preference-based measures: using a discrete choice experim...Valuing paediatric preference-based measures: using a discrete choice experim...
Valuing paediatric preference-based measures: using a discrete choice experim...
 
Does transfer to intensive care units reduce mortality for deteriorating ward...
Does transfer to intensive care units reduce mortality for deteriorating ward...Does transfer to intensive care units reduce mortality for deteriorating ward...
Does transfer to intensive care units reduce mortality for deteriorating ward...
 
Economic evaluation of changes to the organisation and delivery of health ser...
Economic evaluation of changes to the organisation and delivery of health ser...Economic evaluation of changes to the organisation and delivery of health ser...
Economic evaluation of changes to the organisation and delivery of health ser...
 
Quantifying the added societal value of public health interventions in reduci...
Quantifying the added societal value of public health interventions in reduci...Quantifying the added societal value of public health interventions in reduci...
Quantifying the added societal value of public health interventions in reduci...
 

Recently uploaded

Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 

A methodological framework for developing the structure of Public Health economic models

  • 1. A methodological framework for developing the structure of Public Health economic models Dr Hazel Squires, ScHARR, University of Sheffield Prof. Jim Chilcott, Prof. Ron Akehurst, Dr. Jennifer Burr, Prof. Mike Kelly
  • 2. Introduction • Why we need a conceptual modelling framework specific to Economic Modelling in Public Health (PHE) • Methods for developing the PHE conceptual modelling framework • An outline of the PHE conceptual modelling framework • Conclusions
  • 3. Background • Healthcare agencies such as the National Institute for Health and Care Excellence (NICE) need to decide how to spend their money. • Mathematical models are used to provide a rational, coherent & transparent framework of the cost-effectiveness of healthcare interventions. • Inappropriately simple models and lack of justification may lead to poor validity and credibility, resulting in suboptimal allocation of resources.
  • 4. Current methods for dealing with structural uncertainty 1) Retrospective: following model implementation by expressing the impact of uncertainties upon the model results. • Scenario analysis • Model averaging 2) Prospective: considering the process through which decisions are made around the conceptualisation, structuring and implementation of the model. • Model development practice in health economics is extremely varied (Chilcott, 2010). Chilcott J, Tappenden P, Rawdin A, Johnson M, Kaltenthaler E, Paisley S et al. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review. Health Technol Assess 2010; 14(25).
  • 5. What is a Conceptual Modelling (CM) Framework? • ‘A set of steps that help to guide modellers through the development of a model structure, from developing and describing an understanding of the decision problem to the abstraction and non-software specific description of the quantitative model, using a transparent approach which enables each stage to be shared and questioned.’ Based upon Kaltenthaler E., Tappenden P., Paisley S. and Squires H. Identifying and reviewing evidence to inform the conceptualisation and population of cost-effectiveness models, No. 14, 2011 and Robinson S. Conceptual modelling for simulation Part I: definition and requirements. Journal of the Operational Research Society 2008; 59:278-290.
  • 6. Key potential benefits of a CM Framework • Aids the development of modelling objectives; • Provides tools for communication with stakeholders; • Guides model development and experimentation; • Improves model validation (developing the right model); • Improves model verification (developing the model right); • Allows model reuse; • Helps to characterise structural uncertainties and identify primary research needs.
  • 7. Economic evaluation of Public Health compared with clinical interventions • A key objective of Public Health is reduction of health inequities; • PH interventions tend to: - Be multi-component with complex causal chains; - Operate within dynamically complex systems; - Be dependent upon human behaviour; - Be dependent upon the social determinants of health, requiring consideration of non-health costs & outcomes; • It is much less clear what a ‘good’ outcome is; • The culture & politics of the system is important in choosing & assessing interventions
  • 8. Methods for developing PHE conceptual modelling framework 1) Literature review of key challenges in PHE modelling (Squires et al., 2016) 2) Review of conceptual modelling frameworks in broader literature. 3) Qualitative research to understand modellers’ experiences with developing the structure of PH economic models & their views about the benefits/ barriers of using a CM framework. 4) Pilot of the draft CM framework within a case study of diabetes screening & prevention. 5) Evaluation via qualitative analysis & theory-based evaluation. Squires H, Chilcott J, Akehurst R, Burr J, Kelly M. A systematic literature review of the key challenges for developing the structure of public health economic models. Int. J. of Public Health. Epub ahead of print. http://www.ncbi.nlm.nih.gov/pubmed/26747470
  • 9. The CM framework: Key principles (1) A systems approach to Public Health modelling should be taken (feedback loops & unintended consequences are important); (2) Developing a thorough documented understanding of the problem is imperative prior to and alongside developing and justifying the model structure; (3) Strong communication with stakeholders and members of the team throughout model development is essential; (4) A systematic consideration of the determinants of health is central to identifying all key impacts of the interventions within Public Health economic modelling.
  • 11. The CM framework: Key principles (1) A systems approach to Public Health modelling should be taken (feedback loops & unintended consequences are important); (2) Developing a thorough documented understanding of the problem is imperative prior to and alongside developing and justifying the model structure; (3) Strong communication with stakeholders and members of the team throughout model development is essential; (4) A systematic consideration of the determinants of health is central to identifying all key impacts of the interventions within Public Health economic modelling.
  • 12. The CM framework: Key principles (1) A systems approach to Public Health modelling should be taken (feedback loops & unintended consequences are important); (2) Developing a thorough documented understanding of the problem is imperative prior to and alongside developing and justifying the model structure; (3) Strong communication with stakeholders and members of the team throughout model development is essential; (4) A systematic consideration of the determinants of health is central to identifying all key impacts of the interventions within Public Health economic modelling.
  • 13. The CM framework: Key principles (1) A systems approach to Public Health modelling should be taken (feedback loops & unintended consequences are important); (2) Developing a thorough documented understanding of the problem is imperative prior to and alongside developing and justifying the model structure; (3) Strong communication with stakeholders and members of the team throughout model development is essential; (4) A systematic consideration of the determinants of health is central to identifying all key impacts of the interventions within Public Health economic modelling.
  • 14. The determinants of health Dahlgren G., Whitehead M. Policies and strategies to promote social equity in health. 1991. Institute for Future Studies, Stockholm.
  • 15. CM framework overview Aligning the framework with the decision making process Identifying relevant stakeholders Understanding the problem i) Developing a conceptual model of the problem ii) Establishing resource pathways Developing and justifying the model structure i) Reviewing existing economic evaluations ii) Choosing specific model interventions iii) Determining the model boundary iv) Determining the level of detail v) Choosing the model type vi) Developing a qualitative description of the quantitative model
  • 16. CM framework overview Aligning the framework with the decision making process Identifying relevant stakeholders Understanding the problem i) Developing a conceptual model of the problem ii) Establishing resource pathways Developing and justifying the model structure i) Reviewing existing economic evaluations ii) Choosing specific model interventions iii) Determining the model boundary iv) Determining the level of detail v) Choosing the model type vi) Developing a qualitative description of the quantitative model
  • 17. CM framework overview Aligning the framework with the decision making process Identifying relevant stakeholders Understanding the problem i) Developing a conceptual model of the problem ii) Establishing resource pathways Developing and justifying the model structure i) Reviewing existing economic evaluations ii) Choosing specific model interventions iii) Determining the model boundary iv) Determining the level of detail v) Choosing the model type vi) Developing a qualitative description of the quantitative model
  • 18. Stakeholders Stakeholders are identified based upon the classification from Soft Systems Methodology (SSM): • Customers which might include patient representatives and lay members; • Actors which might include clinical experts and epidemiologic experts for all relevant diseases and methods experts; • System owners which might include policy experts (in addition to some of the people identified as actors).
  • 19. CM framework overview Aligning the framework with the decision making process Identifying relevant stakeholders Understanding the problem i) Developing a conceptual model of the problem ii) Establishing resource pathways Developing and justifying the model structure i) Reviewing existing economic evaluations ii) Choosing specific model interventions iii) Determining the model boundary iv) Determining the level of detail v) Choosing the model type vi) Developing a qualitative description of the quantitative model
  • 20. Example conceptual model of the problem Contraception project example: Why is this a problem? _ _ Maximise health Minimise costs to NHS & PSS Minimise costs to other sectors _ _ _ _ _ _ _ _ _ Poor health outcomes of the mother Low birth weight babies + Poor long term socioeconomic outcomes + + + Miscarriage/ stillbirth Abortion Unwanted teenage birth + + + What is the problem? + Unintended teenage pregnancies STIs _ + + Poor contraceptive use by sexually active teenagers (interaction between a male & female) + + Disadvantaged background Competing risks Dependent on history & timing of STIs
  • 21. Questions to help develop diagram: The disease & determinants of health • Have any relevant disease natural histories been captured? • Are the following determinants of health important in determining outcomes & in what way: • Age, sex & other inherent characteristics of the population of interest? • Individual lifestyle factors? • Social and community networks? • Living & working conditions & access to essential goods & services? • General socioeconomic, cultural & environmental conditions?
  • 22. Questions to help develop diagram: Dynamic complexity • Are there any other (positive or negative) consequences of each concept? • Are there any other possible causal links between the factors? (to establish whether there are any feedback loops) • Could there be any other factors which explain both of these outcomes, for links which may not be causal, but correlated? • Are there interactions between different sets of people? • Is timing/ ordering of events important?
  • 23. Questions to help develop diagram: Intervention outcomes • What is a good outcome? • What would happen in the absence of the interventions versus as a result of the interventions – would behaviour be prevented or delayed? • What evidence exists to describe the outcomes of the intervention/ comparator over time? Are behavioural outcomes important? • Are there any determinants of health reported by the effectiveness studies which are not included within the causal diagram? Can such a relationship be described?
  • 24. Questions to help develop diagram: Dynamic complexity of interventions • Might a third party act to reduce or increase the impact of interventions? • Are there any substantial impacts of social and/or community networks upon intervention effectiveness? Will these impacts be captured over the long term within the effectiveness evidence? • Are there any substantial impacts of the interventions upon other lifestyle factors? • Might the interventions have other impacts not already considered?
  • 25. Sources of evidence Starting with high yield sources Individual stakeholder assumptions & beliefs Stakeholder discussion Modeller assumptions & beliefs Project scope Literature sources Existing diagrams/ previous work Conceptual model of the problem
  • 26. CM framework overview Aligning the framework with the decision making process Identifying relevant stakeholders Understanding the problem i) Developing a conceptual model of the problem ii) Establishing resource pathways Developing and justifying the model structure i) Reviewing existing economic evaluations ii) Choosing specific model interventions iii) Determining the model boundary iv) Determining the level of detail v) Choosing the model type vi) Developing a qualitative description of the quantitative model
  • 27. CM framework overview Aligning the framework with the decision making process Identifying relevant stakeholders Understanding the problem i) Developing a conceptual model of the problem ii) Establishing resource pathways Developing and justifying the model structure i) Reviewing existing economic evaluations ii) Choosing specific model interventions iii) Determining the model boundary iv) Determining the level of detail v) Choosing the model type vi) Developing a qualitative description of the quantitative model
  • 28. Develop understanding of the problem Assess whether there is an existing model which could be employed Identify strengths & limitations of different model structures Identify strengths & limitations of different model types Identify key variables which generally affect model results (incl. any not already identified) & key variables included within the causal diagram which do not Identify the sort of data available Identify factors with not many causal links & assess whether they would have a substantial impact upon the difference between outcomes of interventions & comparators Identify types of outcomes reported Identify long term evidence & mechanisms Describe effectiveness of interventions (to help choose which to model & for parameterisation) Model boundary Model detail Model type Discuss potential model perspectives, outcomes, interventions & populations with stakeholders Review existing health economic models Review effectiveness of relevant interventions Review evidence of relationships between factors
  • 29. Does the factor have many causal links? Yes No Is the factor likely to have a substantial impact upon the difference between costs & effects of the interventions? This may be based upon (though not limited to): (1) the review of economic evaluations; (2) the description of resource pathways; (3) clinical papers describing the causal links; (4) existing models in similar areas which describe the impact of the factor; (5) methodological choices eg. discounting; (6) expert advice. Yes No INCLUDE Is the factor associated with the interventions, populations & outcomes being modelled? EXCLUDE INCLUDE EXCLUDE Yes No Yes Is the impact of the factor predominantly captured by other included factors? Yes EXCLUDE No Would stakeholders prefer to include the factor for model credibility AND is it relatively easy to incorporate in terms of modelling skill & data availability? INCLUDE No Will the model only assess one intervention AND is the intervention likely to be cost-effective AND does the factor only further increase benefits Yes No Determining the model boundary
  • 31. Determining level of detail Key types of model assumptions/ simplifications: 1. The relationship between the included factors over time; 2. The extrapolation of study outcomes; 3. The level of detail used to describe each included factor; 4. How interventions will be implemented in practice. Questions to help the modeller for each of these are proposed within the framework.
  • 32. Choosing model type (1) A B C D Cohort/ aggregate level/ counts Individual level Expected value, continuous state, deterministic Markovian, discrete state, stochastic Markovian, discrete state Non-Markovian, discrete state 1 No interaction Untimed Decision tree rollback Simulation decision tree Individual sampling model: Simulated patient-level decision tree 2 Timed Markov model (deterministic) Simulation Markov model Individual sampling model: Simulated patient-level Markov model 3 Interaction between entity and environment Discrete time System dynamics (finite difference equations) Discrete time Markov chain model Discrete-time individual event history model Discrete individual simulation 4 Continuous time System dynamics (ordinary differential equations) Continuous time Markov chain model Continuous time individual event history model Discrete event simulation 5 Strong interactions between entities. Spatial aspects important. X X X Agent-based simulation Revised version of taxonomy by Brennan A, Chick SE, Davies R. A taxonomy of model structures for economic evaluation of health technologies. Health Econ 2006; 15(12):1295-1310.
  • 33. Choosing model type (2) Determine the most appropriate model type for the characteristics of the problem. Is this feasible within the time and resource constraints of the decision making process given: (i) the data available? AND (ii) the accessibility of any existing relevant good quality economic evaluations for use as a starting point? AND (iii) the expertise of the modeller? Are you intending to use the model again for other projects? Can you answer the decision makers’ question with a few provisos and uncertainties with a simpler model type? Yes No Explore with the decision maker the most useful purpose of the modelling given the project constraints Develop the simpler model type, documenting the provisos, uncertainties & implications of the simplifications NoYes Do you think a simpler model type would lead to the same conclusions? Develop the model Yes No Develop the more complex model Develop the simpler model, documenting the provisos, uncertainties & implications of the simplifications Yes No
  • 34. Conclusions • Very little research has been undertaken around conceptual modelling in health economic evaluation. • We have developed a conceptual modelling framework for use within Public Health economic models (paper under review). • This has yet to be tested on a range of case studies. • If anybody wants to know more about the framework or potentially use it, let me know! Email: h.squires@sheffield.ac.uk PhD thesis: http://etheses.whiterose.ac.uk/5316/